Mersana Therapeutics, Inc. (MRSN) Financial Statements (2024 and earlier)

Company Profile

Business Address 840 MEMORIAL DRIVE
CAMBRIDGE, MA 02139
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments128,885177,947255,09499,79070,131114,734
Cash and cash equivalents128,885177,947255,09462,35159,63426,591
Short-term investments    37,43910,49788,143
Receivables 30,000   459784
Other undisclosed current assets160,33410,9513,4861,5363,7152,025
Total current assets:319,219188,898258,580101,32674,305117,543
Noncurrent Assets
Operating lease, right-of-use asset10,47512,88910,9362,598
Property, plant and equipment 3,9851,9681,7302,1642,6942,319
Long-term investments and receivables      10,482
Long-term investments      10,482
Restricted cash and investments      
Other noncurrent assets6612,3562,1531,4531,503371
Other undisclosed noncurrent assets      
Total noncurrent assets:15,12117,21314,8196,2154,19713,172
TOTAL ASSETS:334,340206,111273,399107,54178,502130,715
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities57,13541,03724,48616,28223,10210,014
Accounts payable13,95112,3218,3407,29610,7273,070
Accrued liabilities43,18428,71616,1468,98612,3756,944
Deferred revenue30,6103,9443,9874,815
Debt 240239932,886  
Deferred rent credit     127
Deferred revenue and credits21,867
Contract with customer, liability46,196
Other liabilities9902399387  
Other undisclosed current liabilities2,5582,0641,344   
Total current liabilities:91,53347,52330,00324,07069,42531,881
Noncurrent Liabilities
Long-term debt and lease obligation24,92935,87315,1354,878  
Long-term debt, excluding current maturities24,92924,6264,9774,201  
Liabilities, other than long-term debt125,82197417427528228,840
Deferred revenue and credits28,840
Deferred revenue117,043   
Deferred rent credit     282
Other liabilities203974174275  
Operating lease, liability8,57511,24710,158677
Other undisclosed noncurrent liabilities      
Total noncurrent liabilities:150,75036,84715,3095,15328228,840
Total liabilities:242,28384,37045,31229,22369,70760,721
Equity
Equity, attributable to parent92,057121,741228,08778,3188,79569,994
Common stock1177533
Additional paid in capital746,889572,213508,499270,662172,966168,018
Accumulated other comprehensive income (loss)(152)  25(8)(149)
Accumulated deficit(654,691)(450,479)(280,419)(192,374)(164,166)(97,878)
Total equity:92,057121,741228,08778,3188,79569,994
TOTAL LIABILITIES AND EQUITY:334,340206,111273,399107,54178,502130,715

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues26,5814382842,12310,59417,545
Gross profit:26,5814382842,12310,59417,545
Operating expenses(230,348)(168,901)(88,938)(72,323)(76,249)(57,162)
Operating loss:(203,767)(168,858)(88,110)(30,200)(65,655)(39,617)
Nonoperating income (expense)(445)(1,202)651,9921,398910
Investment income, nonoperating2,883654242,226  
Interest and debt expense(3,328)(1,267)(359)(234)  
Loss from continuing operations:(207,540)(171,327)(88,404)(28,442)(64,257)(38,707)
Loss before gain (loss) on sale of properties:(171,327)(88,404)(28,442)(64,257)(38,707)
Other undisclosed net income3,3281,267359234  
Net loss:(204,212)(170,060)(88,045)(28,208)(64,257)(38,707)
Other undisclosed net income attributable to parent      
Net loss available to common stockholders, diluted:(204,212)(170,060)(88,045)(28,208)(64,257)(38,707)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(204,212)(170,060)(88,045)(28,208)(64,257)(38,707)
Other comprehensive income (loss)(152) (25)33141(149)
Other undisclosed comprehensive loss      
Comprehensive loss:(204,364)(170,060)(88,070)(28,175)(64,116)(38,856)
Other undisclosed comprehensive income, net of tax, attributable to parent      
Comprehensive loss, net of tax, attributable to parent:(204,364)(170,060)(88,070)(28,175)(64,116)(38,856)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: